Liquidia Technologies, Inc. (LQDA): Price and Financial Metrics

Liquidia Technologies, Inc. (LQDA): $6.85

-0.05 (-0.72%)

POWR Rating

Component Grades














  • LQDA scores best on the Sentiment dimension, with a Sentiment rank ahead of 66.22% of US stocks.
  • The strongest trend for LQDA is in Growth, which has been heading up over the past 177 days.
  • LQDA's current lowest rank is in the Stability metric (where it is better than 21.63% of US stocks).

LQDA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for LQDA is 0.15 -- better than merely 14.79% of US stocks.
  • LQDA's price/sales ratio is 32.27; that's higher than the P/S ratio of 95.35% of US stocks.
  • With a year-over-year growth in debt of 51.26%, LIQUIDIA CORP's debt growth rate surpasses 80.7% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to LIQUIDIA CORP, a group of peers worth examining would be KIND, RAMP, SUMO, LIDR, and ASAN.
  • LQDA's SEC filings can be seen here. And to visit LIQUIDIA CORP's official web site, go to

LQDA Valuation Summary

  • LQDA's price/sales ratio is 29.4; this is 1300% higher than that of the median Healthcare stock.
  • Over the past 55 months, LQDA's price/earnings ratio has gone down 3.

Below are key valuation metrics over time for LQDA.

Stock Date P/S P/B P/E EV/EBIT
LQDA 2023-01-30 29.4 4.3 -8.8 -7.5
LQDA 2023-01-27 31.2 4.5 -9.4 -8.1
LQDA 2023-01-26 31.6 4.6 -9.5 -8.2
LQDA 2023-01-25 32.5 4.7 -9.7 -8.5
LQDA 2023-01-24 32.3 4.7 -9.7 -8.4
LQDA 2023-01-23 30.3 4.4 -9.1 -7.8

LQDA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LQDA has a Quality Grade of D, ranking ahead of 6.72% of graded US stocks.
  • LQDA's asset turnover comes in at 0.106 -- ranking 153rd of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows LQDA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.106 0.756 -1.103
2021-06-30 0.075 0.771 -1.558
2021-03-31 0.049 0.756 -2.131
2020-12-31 0.011 0.679 -2.776
2020-09-30 0.000 NA -3.022
2020-06-30 0.000 NA -2.692

LQDA Price Target

For more insight on analysts targets of LQDA, see our LQDA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $4.25 Average Broker Recommendation 1.5 (Moderate Buy)

LQDA Stock Price Chart Interactive Chart >

Price chart for LQDA

LQDA Price/Volume Stats

Current price $6.85 52-week high $8.79
Prev. close $6.90 52-week low $3.26
Day low $6.69 Volume 231,758
Day high $6.97 Avg. volume 535,976
50-day MA $6.13 Dividend yield N/A
200-day MA $5.46 Market Cap 441.79M

Liquidia Technologies, Inc. (LQDA) Company Bio

Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase Ib clinical trials for the treatment of local post-operative pain. The company was founded in 2004 and is based in Morrisville, North Carolina.

LQDA Latest News Stream

Event/Time News Detail
Loading, please wait...

LQDA Latest Social Stream

Loading social stream, please wait...

View Full LQDA Social Stream

Latest LQDA News From Around the Web

Below are the latest news stories about LIQUIDIA CORP that investors may wish to consider to help them evaluate LQDA as an investment opportunity.

Decision moves Liquidia, United Therapeutics patent dispute toward resolution

A patent dispute between Liquidia and United Therapeutics is potentially nearing a resolution after a recent decision by a federal patent board.

Yahoo | February 6, 2023

LQDA (Liquidia Corporation) has powerful results

As of Thursday, Liquidia Corporation’s (NASDAQ:LQDA) stock closed at $7.01, up from $6.39 the previous day. While Liquidia Corporation has overperformed by 9.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LQDA rose by 16.83%, with highs and lows ranging from $8.79 to $3.26, whereas the […]

US Post News | February 3, 2023

Strength Seen in Liquidia Technologies, Inc. (LQDA): Can Its 9.7% Jump Turn into More Strength?

Liquidia Technologies, Inc. (LQDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | February 3, 2023

Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)

PTAB rejects UTHR’s request for rehearing of its decision in the inter partes review of the ‘793 Patent (‘793 IPR)PTAB clarified grounds upon which it based its finding that the cited publications, which invalidated the claims, constituted prior artCompany reaffirms expectation of legal resolution in late 2023 or the first half of 2024 MORRISVILLE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) announced that the PTAB has reaffirmed its orig

Yahoo | February 2, 2023

Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant of inducement stock options exercisable for an aggregate of 10,000 shares of Liquidia’s common stock to newly hired non-executive employees under the Liquidia Corporation 2022 Inducement Plan (the “Inducement Plan”). Each stock option was granted as an inducement material to the grantee’s acceptance of employment with Liquidia (or one of its subsidiaries) as a component of the grant

Yahoo | February 2, 2023

Read More 'LQDA' Stories Here

LQDA Price Returns

1-mo 19.76%
3-mo 37.55%
6-mo 19.96%
1-year 6.04%
3-year 13.41%
5-year N/A
YTD 7.54%
2022 30.80%
2021 65.08%
2020 -30.99%
2019 -80.26%
2018 N/A

Continue Researching LQDA

Want to see what other sources are saying about Liquidia Technologies Inc's financials and stock price? Try the links below:

Liquidia Technologies Inc (LQDA) Stock Price | Nasdaq
Liquidia Technologies Inc (LQDA) Stock Quote, History and News - Yahoo Finance
Liquidia Technologies Inc (LQDA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8429 seconds.